{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T03:11:37Z","timestamp":1740107497386,"version":"3.37.3"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2021,6,29]],"date-time":"2021-06-29T00:00:00Z","timestamp":1624924800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,6,29]],"date-time":"2021-06-29T00:00:00Z","timestamp":1624924800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Parasitol Res"],"published-print":{"date-parts":[[2021,8]]},"DOI":"10.1007\/s00436-021-07232-6","type":"journal-article","created":{"date-parts":[[2021,6,29]],"date-time":"2021-06-29T06:02:39Z","timestamp":1624946559000},"page":"2855-2861","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["The immune response against Toxoplasma gondii in BALB\/c mice induced by mannose-modified nanoliposome of excreted\/secreted antigens"],"prefix":"10.1007","volume":"120","author":[{"given":"Seyed Hossein","family":"Abdollahi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hasan Ebrahimi","family":"Shahmabadi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammad Kazemi","family":"Arababadi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nahid","family":"Askari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3539-8982","authenticated-orcid":false,"given":"Soudeh Khanamani","family":"Falahati-pour","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,6,29]]},"reference":[{"issue":"6","key":"7232_CR1","doi-asserted-by":"publisher","first-page":"530","DOI":"10.3923\/pjbs.2009.530.533","volume":"12","author":"SH Abdollahi","year":"2009","unstructured":"Abdollahi SH, Arababadi MK, Hassanshahi G (2009) Evaluation of excreted\/secreted antigens derived from peritoneal of toxoplasma infected small mice to detect IgG against Toxoplasma. Pak J Biol Sci 12(6):530\u2013533","journal-title":"Pak J Biol Sci"},{"key":"7232_CR2","doi-asserted-by":"publisher","first-page":"1559","DOI":"10.1007\/s00436-019-06257-2","volume":"118","author":"MPO Almeida","year":"2019","unstructured":"Almeida MPO, Ferro EAV, Brice\u00f1o MPP, Oliveira MC, Barbosa BF, Silva NM (2019) Susceptibility of human villous (BeWo) and extravillous (HTR-8\/SVneo) trophoblast cells to Toxoplasma gondii infection is modulated by intracellular iron availability. Parasitol Res 118:1559\u20131572","journal-title":"Parasitol Res"},{"key":"7232_CR3","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1086\/315186","volume":"181","author":"C Angus","year":"2000","unstructured":"Angus C, Klivington-Evans D, Dubey J, Kovacs JA (2000) Immunization with a DNA plasmid encoding the SAG1 (P30) protein of Toxoplasma gondii is immunogenic and protective in rodents. J Infect Dis 181:317\u2013324","journal-title":"J Infect Dis"},{"key":"7232_CR4","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1111\/j.1600-0463.2009.02453.x","volume":"117","author":"IJ Blader","year":"2009","unstructured":"Blader IJ, Saeij JP (2009) Communication between Toxoplasma gondii and its host: impact on parasite growth, development, immune evasion, and virulence. Apmis 117:458\u2013476","journal-title":"Apmis"},{"key":"7232_CR5","doi-asserted-by":"publisher","first-page":"2897","DOI":"10.1007\/s00436-020-06795-0","volume":"119","author":"NB Bottari","year":"2020","unstructured":"Bottari NB et al (2020) Neuroprotective role of resveratrol mediated by purinergic signalling in cerebral cortex of mice infected by Toxoplasma gondii. Parasitol Res 119:2897\u20132905","journal-title":"Parasitol Res"},{"key":"7232_CR6","doi-asserted-by":"crossref","first-page":"3496","DOI":"10.4049\/jimmunol.147.10.3496","volume":"147","author":"R B\u00fclow","year":"1991","unstructured":"B\u00fclow R, Boothroyd J (1991) Protection of mice from fatal Toxoplasma gondii infection by immunization with p30 antigen in liposomes. J Immunol 147:3496\u20133500","journal-title":"J Immunol"},{"key":"7232_CR7","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1111\/j.1365-3024.2008.01025.x","volume":"30","author":"YL Cui","year":"2008","unstructured":"Cui YL, He SY, Xue MF, Zhang J, Wang HX, Yao Y (2008) Protective effect of a multiantigenic DNA vaccine against Toxoplasma gondii with co-delivery of IL-12 in mice. Parasite Immunol 30:309\u2013313","journal-title":"Parasite Immunol"},{"key":"7232_CR8","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1111\/j.1365-3024.1988.tb00242.x","volume":"10","author":"F Darcy","year":"1988","unstructured":"Darcy F et al (1988) Induction of a protective antibody-dependent response against toxoplasmosis by in vitro excreted\/secreted antigens from tachyzoites of Toxoplasma gondii. Parasite Immunol 10:553\u2013567","journal-title":"Parasite Immunol"},{"key":"7232_CR9","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/S0304-4017(03)00044-X","volume":"113","author":"A Daryani","year":"2003","unstructured":"Daryani A, Hosseini AZ, Dalimi A (2003) Immune responses against excreted\/secreted antigens of Toxoplasma gondii tachyzoites in the murine model. Vet Parasitol 113:123\u2013134","journal-title":"Vet Parasitol"},{"key":"7232_CR10","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.exppara.2009.06.002","volume":"123","author":"B Dziadek","year":"2009","unstructured":"Dziadek B, Gatkowska J, Brzostek A, Dziadek J, Dzitko K, Dlugonska H (2009) Toxoplasma gondii: the immunogenic and protective efficacy of recombinant ROP2 and ROP4 rhoptry proteins in murine experimental toxoplasmosis. Exp Parasitol 123:81\u201389","journal-title":"Exp Parasitol"},{"doi-asserted-by":"crossref","unstructured":"El-Malky M et al. (2005) Protective effect of vaccination with Toxoplasma lysate antigen and CpG as an adjuvant against Toxoplasma gondii in susceptible C57BL\/6 mice. Microbiol Immunol 49:639\u2013 646","key":"7232_CR11","DOI":"10.1111\/j.1348-0421.2005.tb03656.x"},{"key":"7232_CR12","doi-asserted-by":"publisher","first-page":"174","DOI":"10.3109\/14764172.2015.1039040","volume":"18","author":"Z Fakhravar","year":"2016","unstructured":"Fakhravar Z, Ebrahimnejad P, Daraee H, Akbarzadeh A (2016) Nanoliposomes: synthesis methods and applications in cosmetics. J Cosmetic Laser Ther 18:174\u2013181","journal-title":"J Cosmetic Laser Ther"},{"doi-asserted-by":"crossref","unstructured":"Hiszczy\u0144ska-Sawicka E et al (2012) Induction of immune responses in sheep by vaccination with liposome-entrapped DNA complexes encoding Toxoplasma gondii MIC3 gene. Pol J Vet Sci 15(1):3\u20139","key":"7232_CR13","DOI":"10.2478\/v10181-011-0107-7"},{"doi-asserted-by":"crossref","unstructured":"Innes EA, Bartley PM, Maley S, Katzer F, Buxton D (2009) Veterinary vaccines against Toxoplasma gondii Mem\u00f3rias do instituto oswaldo cruz 104:246-251","key":"7232_CR14","DOI":"10.1590\/S0074-02762009000200018"},{"doi-asserted-by":"crossref","unstructured":"Konstantinovic N, Guegan H, St\u00e4jner T, Belaz S, Robert-Gangneux F (2019) Treatment of toxoplasmosis: current options and future perspectives. Food Waterborne Parasitol 15:e00036","key":"7232_CR15","DOI":"10.1016\/j.fawpar.2019.e00036"},{"key":"7232_CR16","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1111\/j.1600-0463.2010.02629.x","volume":"118","author":"D Kotresha","year":"2010","unstructured":"Kotresha D, Noordin R (2010) Recombinant proteins in the diagnosis of toxoplasmosis. APMIS 118:529\u2013542","journal-title":"APMIS"},{"key":"7232_CR17","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/j.exppara.2008.03.016","volume":"119","author":"YL Lau","year":"2008","unstructured":"Lau YL, Fong MY (2008) Toxoplasma gondii: serological characterization and immunogenicity of recombinant surface antigen 2 (SAG2) expressed in the yeast Pichia pastoris. Exp Parasitol 119:373\u2013378","journal-title":"Exp Parasitol"},{"doi-asserted-by":"crossref","unstructured":"Lee Y-H, Shin D-W, Lee J-H, Nam H-W, Ahn M-H (2007) Vaccination against murine toxoplasmosis using recombinant Toxoplasma gondii SAG3 antigen alone or in combination with Quil A. Yonsei Med J 48(3):396\u2013404","key":"7232_CR18","DOI":"10.3349\/ymj.2007.48.3.396"},{"key":"7232_CR19","doi-asserted-by":"publisher","first-page":"2703","DOI":"10.1007\/s00436-020-06766-5","volume":"119","author":"NI Machado","year":"2020","unstructured":"Machado NI, Dos Santos TAT, de Souza W, DaMatta RA, Seabra SH (2020) Treatment with melatonin induces a reduction of Toxoplasma gondii development in LLC-MK2 cells. Parasitol Res 119:2703\u20132711","journal-title":"Parasitol Res"},{"key":"7232_CR20","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.2217\/nnm.16.9","volume":"11","author":"TX Nguyen","year":"2016","unstructured":"Nguyen TX, Huang L, Gauthier M, Yang G, Wang Q (2016) Recent advances in liposome surface modification for oral drug delivery. Nanomedicine 11:1169\u20131185","journal-title":"Nanomedicine"},{"doi-asserted-by":"crossref","unstructured":"Perrie Y, Crofts F, Devitt A, Griffiths HR, Kastner, Elisabeth and Nadella, Vinod (2016) Designing liposomal adjuvants for the next generation of vaccines. Advanced Drug Delivery Reviews, 99 (Pt A). pp. 85\u201396. ISSN 0169\u2013409X","key":"7232_CR21","DOI":"10.1016\/j.addr.2015.11.005"},{"doi-asserted-by":"crossref","unstructured":"Suzuki Y (2020) The immune system utilizes two distinct effector mechanisms of T cells depending on two different life cycle stages of a single pathogen, Toxoplasma gondii, to control its cerebral infection. Parasitol Int 76:102030","key":"7232_CR22","DOI":"10.1016\/j.parint.2019.102030"},{"key":"7232_CR23","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.jconrel.2019.04.025","volume":"303","author":"N Wang","year":"2019","unstructured":"Wang N, Chen M, Wang T (2019) Liposomes used as a vaccine adjuvant-delivery system: From basics to clinical immunization. J Control Release 303:130\u2013150","journal-title":"J Control Release"},{"key":"7232_CR24","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1080\/00034983.1998.11813257","volume":"92","author":"Y Yamamoto","year":"1998","unstructured":"Yamamoto Y, Mineo J, Meneghisse C, Guimaraes A, Kawarabayashi M (1998) Detection in human sera to excreted secreted antigens Toxoplasma gondii by use immunoblot assay of IgG, IgM and IgA from of dot. ELISA Annals Trop Med Parasitol 92:23\u201330","journal-title":"ELISA Annals Trop Med Parasitol"},{"doi-asserted-by":"crossref","unstructured":"Zhao Y et al (2020) Mannose-modified liposome co-delivery of human papillomavirus type 16 E7 peptide and CpG oligodeoxynucleotide adjuvant enhances antitumor activity against established large TC-1 grafted tumors in mice. Int J Nanomed 15:9571\u20139586","key":"7232_CR25","DOI":"10.2147\/IJN.S275670"}],"container-title":["Parasitology Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00436-021-07232-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00436-021-07232-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00436-021-07232-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,5]],"date-time":"2023-11-05T11:54:14Z","timestamp":1699185254000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00436-021-07232-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6,29]]},"references-count":25,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2021,8]]}},"alternative-id":["7232"],"URL":"https:\/\/doi.org\/10.1007\/s00436-021-07232-6","relation":{},"ISSN":["0932-0113","1432-1955"],"issn-type":[{"type":"print","value":"0932-0113"},{"type":"electronic","value":"1432-1955"}],"subject":[],"published":{"date-parts":[[2021,6,29]]},"assertion":[{"value":"24 May 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 June 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 June 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declaration"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}